Pines City Colleges
(Owned and operated by THORNTON`S INTERNATIONAL STUDIES, INC.)
Magsaysay Ave. Baguio City 2600
College of Nursing
DRUG STUDY
Submitted to: Ms. Marjorie Ilonen
Submitted by: Shannon Cabfit
December 06, 2022
BETAHISTINE
NAME OF DRUG MODE OF ACTION INDICATION
Generic Name: Betahistine was found to have a Meniere’s disease, Meniere-like
Serc histamine-like action in animals. syndrome (with symptoms of
Since parenteral histamine has vertigo, tinnitus, and
Brand Name: been used in the treatment of sensorineural deafness), and
Betahistine dihydrochloride Meniere's disease, studies were vertigo of peripheral origin.
conducted to test the action of
Classification: betahistine in this condition.
Anti emetics and Anti vertigo Unlike some other anti-vertigo
drugs, testing with nystagmus
Dosage: induced by caloric and
rotational stimulation has
Route: demonstrated that betahistine
does not decrease the
vestibular response, as
recorded by
electronystagmography.
However, clinical studies
indicate that SERC may be
useful in reducing the vertigo of
Meniere's disease.
CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
Previous hypersensitive Occasionally patients have Avoid contact of oral solution or
reaction to the drug experienced gastric upset, injection with skin
components nausea and headache, Urticaria,
Pruritus, False heartbeat, Raise bed rails, institute safety
Insomnia measures, supervise ambulation
Advise relatives to support
patient’s ambulation
CINNARIZINE
NAME OF DRUG MODE OF ACTION INDICATION
Brand Name: Cinnarizine inhibits contractions Maintenance therapy for
Stugeron Forte of vascular smooth muscle cells symptoms of labyrinthine
by blocking L-type and T-type disorders, including vertigo,
Generic Name: voltage-gated calcium channels. dizziness, tinnitus, nystagmus,
Cinnarizine Cinnarizine has also been nausea, and vomiting
implicated in binding to
Classification: dopamine D2 receptors,
Anti vertigo histamine H1 receptors, and
muscarinic acetylcholine
Dosage: receptors.
Route:
Oral
CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
Patients with known Significant: Epigastric As with other antihistamines,
hypersensitivity to cinnarizine discomfort, drowsiness; new- cinnarizine may cause epigastric
onset or aggravation of distress; taking it after meals
parkinsonian symptoms. may diminish gastric irritation.
Gastrointestinal disorders:
Nausea, vomiting, dry mouth. Cinnarizine may cause
General disorders and somnolence, especially at the
administration site conditions: start of treatment. Therefore,
Fatigue. caution should be taken when
Immune system disorders: A alcohol or CNS depressants are
hypersensitivity reaction. used concomitantly
Investigations: Increased
weight.
Nervous system disorders:
Headache.
Psychiatric disorders:
Hypersomnia.
Skin and subcutaneous tissue
disorders: Hyperhidrosis,
lichenoid keratosis (including
lichen planus).
METOCLOPRAMIDE
NAME OF DRUG MODE OF ACTION INDICATION
Brand Name: Stimulates motility of the upper Symptomatic treatment of
Reglan GI tract. diabetic gastroparesis,
Blocks dopamine/serotonin placement of enteral feeding
Generic Name: receptors in the chemoreceptor tubes, prevent/treat
Metoclopramide trigger zone. nausea/vomiting with
Enhances acetylcholine chemotherapy or after surgery.
Classification: response in upper GI tract;
Dopamine receptor antagonist increases lower esophageal
sphincter tone.
Dosage:
10mg
Route:
IVTT
CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
Concurrent use of medications Drowsiness, restlessness, Assess for dehydration (poor
likely to produce extrapyramidal fatigue, lethargy, dizziness, skin turgor, dry mucous
reactions, GI hemorrhage, GI anxiety, headache, insomnia, membranes, longitudinal
obstruction/perforation, History breast tenderness, altered furrows in tongue).
of seizure disorder, and menstruation, constipation, Assess for nausea, vomiting,
Pheochromocytoma. rash, dry mouth, galactorrhea, abdominal distention, and
Cautions: Renal impairment, HF, gynecomastia, hypotension, bowel sounds.
cirrhosis, hypertension, hypertension, tachycardia
depression, Parkinson’s disease, Observe 10 rights in drug
elderly administration.
Assess for allergy to
metoclopramide.
Assess for other
contraindications
Monitor for anxiety,
restlessness, and
extrapyramidal symptoms (EPS)
during IV administration.
Monitor daily pattern of bowel
activity, and stool consistency.
Assess skin for rash.
Monitor diabetic patients
NEUROAID
NAME OF DRUG MODE OF ACTION INDICATION
Generic Name: NeuroAiD boots the brain repair Traditionally used for general
mechanisms by stimulating the health maintenance and
Brand Name: generation of new neural cells strengthening the body.
and favoring the formation of
Classification: new functional neuronal circuits
to repair the damaged areas.
Dosage:
2 capsule
Route:
Oral
CONTRAINDICATION ADVERSE EFFECT NURSING RESPONSIBILITIES
Contraindicated in pregnant Dry mouth, nausea, vomiting, Assess for nausea, vomiting,
and breastfeeding women abdominal discomfort, diarrhea, abdominal distention, and
and headache. bowel sounds.
Observe 10 rights in drug
administration.
Assess for any allergy
Monitor vital sign
Assess for dehydration